Cargando…

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.

During a clinical trial of duration of chemotherapy in small cell lung cancer (SCLC), 71 of 610 patients (11.6%) died in the first 3 weeks. Chemotherapy consisted of cyclophosphamide 1 g m-2 i.v. day 1, etoposide 100 mg t.d.s. orally days 1-3, vincristine 2 mg i.v. day 1. The time of death was found...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morittu, L., Earl, H. M., Souhami, R. L., Ash, C. M., Tobias, J. S., Geddes, D. M., Harper, P. G., Spiro, S. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247207/ https://www.ncbi.nlm.nih.gov/pubmed/2544222

Ejemplares similares

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.
por: Twelves, C. J., et al.
Publicado: (1990)

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
por: Spiro, S. G., et al.
Publicado: (1989)

Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients.
por: Goldman, J. M., et al.
Publicado: (1989)

A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
por: Earl, H. M., et al.
Publicado: (1991)

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.
por: James, L. E., et al.
Publicado: (1996)

Long-Term Neurotoxicity of Chemotherapy in Adolescents and Young Adults Treated for Bone and Soft Tissue Sarcomas
por: Earl, Helena M., et al.
Publicado: (1998)

The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.
por: Olabiran, Y., et al.
Publicado: (1994)

Chemotherapy for osteosarcoma.
por: Souhami, R. L.
Publicado: (1989)

Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research.
por: Souhami, R. L., et al.
Publicado: (1990)

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
por: Faria, Sergio L, et al.
Publicado: (2006)

The Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Owen, Scott, et al.
Publicado: (2014)

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients
por: de Jong, Corine, et al.
Publicado: (2022)

Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer
por: Harada, Guilherme, et al.
Publicado: (2021)

Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer.
por: Lee, C. R., et al.
Publicado: (1993)

The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer
por: Zhou, Ning-ning, et al.
Publicado: (2018)

Retrospective study of the efficacy and toxicity of lobaplatin‐etoposide chemotherapy in small cell lung cancer
por: Gu, Liyan, et al.
Publicado: (2019)

An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
por: Bobrow, L. G., et al.
Publicado: (1992)

Neutrophil function during chemotherapy for Hodgkin's disease.
por: Gandossini, M., et al.
Publicado: (1981)

Chemotherapy-induced pulmonary toxicity in lung cancer management
por: Cutillas, Jorge Roig, et al.
Publicado: (2001)

Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy
por: Zhang, Ling, et al.
Publicado: (2012)

Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study
por: Arrieta, Oscar, et al.
Publicado: (2010)

Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.
por: Thatcher, N., et al.
Publicado: (1985)

Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients
por: Liu, Jun-Yan, et al.
Publicado: (2017)

Lung cancer: principles and practice
por: Spiro, S G
Publicado: (2001)

Research in progress—LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group
por: Spiro, Stephen G, et al.
Publicado: (2016)

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.
por: Tierney, J. F., et al.
Publicado: (1995)

Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy
por: Owen, Daniel R., et al.
Publicado: (2021)

Toxicities of Immunotherapy for Small Cell Lung Cancer
por: Fu, Yang, et al.
Publicado: (2021)

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
por: Ahmedzai, S., et al.
Publicado: (1983)

Chemotherapy of non-small cell lung cancer.
por: Williams, C. J.
Publicado: (1989)

Radiotherapy Dose and Induction Chemotherapy Cycles Are Associated With Prognosis and Toxicity Risk: A Retrospective Study of 227 Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
por: Chen, Liyao, et al.
Publicado: (2020)

The Association between COX-2 Polymorphisms and Hematologic Toxicity in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy
por: Zhou, Fei, et al.
Publicado: (2013)

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
por: Hickish, T. F., et al.
Publicado: (1998)

Genetic variants as predictors of toxicity and response in patients with non‐small cell lung cancer undergoing first‐line platinum‐based chemotherapy: Design of the multicenter PGxLUNG study
por: de Jong, Corine, et al.
Publicado: (2020)

IASLC Textbook of Prevention and Early Detection of Lung Cancer
por: Spiro, S G
Publicado: (2006)

The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study
por: Dorling, Leila, et al.
Publicado: (2016)

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression
por: Lassen, U N, et al.
Publicado: (1999)

Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
por: Spasic, Jelena, et al.
Publicado: (2022)

Update on Lung Cancer and Mesothelioma
por: Brown, Jerry S, et al.
Publicado: (1999)

Early toxicity predicts long-term survival in high-grade glioma
por: Lawrence, Y R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d7gj42b0lofebi4gs39oc4560l